Serglycin as a potential biomarker for glioma: association of serglycin expression, extent of mast cell recruitment and glioblastoma progression

Serglycin is an intracellular proteoglycan with a unique ability to adopt highly divergent structures by glycosylation with variable types of glycosaminoglycans (GAGs) when expressed by different cell types. Serglycin is overexpressed in aggressive cancers suggesting its protumorigenic role. In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Roy, Ananya, Attarha, Sanaz, Weishaupt, Holger, Edqvist, Per-Henrik, Swartling, Fredrik J., Bergqvist, Michael, Siebzehnrubl, Florian A., Smits, Anja, Pontén, Fredrik, Tchougounova, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421891/
https://www.ncbi.nlm.nih.gov/pubmed/28445977
http://dx.doi.org/10.18632/oncotarget.15820

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421891/
https://www.ncbi.nlm.nih.gov/pubmed/28445977
http://dx.doi.org/10.18632/oncotarget.15820

Ejemplares similares